Moreover, other natural products, such as silibinin, the major active constituent of silymarin, show potential to ameliorate palmitate-induced insulin resistance in C2C12 myotubes through increased insulin-stimulated glucose uptake and via modulation of the IRS1/PI3K/AKT pathway [42]. The gene discussed is AKT1; the disease is Insulin resistance.